A new treatment option for adults with secondary Human growth hormone deficiency is synthetic HGH. According to current research, both metabolic and psychosomatic illnesses related to HGH deficiency can often be successfully treated with human growth hormone replacement therapy in small doses that do not result in any negative side effects.

With Hgh supplements your body goes through compositional changes. Lean mass is developed and fat masses become denser. The development of lean mass is associated with an increase is muscle mass and function as well as an increased protein mixture. After six months of HGH replacement therapy anyone can expect to reduce their total body fat. Fat loss is most significant in trunk and visceral areas as oppose to the extremities and neck which suggests a reversal of the redistribution of fat resultant from HGH deficit and the associated cardiovascular risks.

Human growth hormone replacement therapy may also have a beneficial effect on lipids. It was reported that short courses of HGH lowered LDL cholesterol and this reduction connected with augmented mRNA expression of the LDL receptor in the liver. The likely advantage of this interaction has yet to be looked into in longer term clinical trials, but it must be noted that drastic changes in serum lipid levels are not always seen with HGH administration.

It has been discovered that body composition, bone density, lipid metabolism, cardiovascular function and emotional health can be helped through the use of Testosterone replacement therapy. There are still many issues to be looked into, including determining a precise clinical definition of partial vs. complete HGH deficiency and deciding which tests work best to make this determination. It is also not clear if some of the positive effects found in experiments reflected human growth hormone therapy through drugs rather than through the replacement therapy.

Nonetheless, it is obvious that small doses may be enough to achieve the wanted metabolic results. Ultimate recommendation on dosage and the long term effects of HGH therapy, mainly on cardiovascular morbidity and mortality, will be figured out by the potential studies.

Even though HGH levels decline with age, it has not been proven that trying to preserve the amounts that survive in young people is preferred. It is possible that age-related hormonal changes may be useful markers of physiological aging. However, this has not been demonstrated experimentally for humans. Although hormone-replacement examinations have given some constructive results, it is clear that bad side effects can also happen in the form of risks for cancer, cardiovascular disease, and behavior alterations.